Domestic manufacturing, stable procurement, and transportation cost reduction | GMP compliant: Contract manufacturing service for liquid media for regenerative medicine.
Our company provides contract manufacturing of liquid media for customers in regenerative medicine, including iPS cells and mesenchymal stem cells. We perform aseptic filling into containers tailored to customer requirements. We can accommodate bottles and single-use bags. You can trust us to handle your needs with confidence. Please feel free to contact us with your requests. 【Factory Features】 ■ GMP-compliant manufacturing environment - Cleanliness, temperature and humidity, differential pressure management, environmental monitoring ■ Production line adapted for small quantities and diverse products - Extensive use of single-use equipment - Simple filling line - Smooth transition from research use to clinical use ■ Strict management of raw materials - Raw materials compliant with biological origin standards *Consultation for implementation audits is available. *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
For more details, please download the PDF or contact us.
Price information
Please contact us separately.
Delivery Time
※It will vary depending on the quantity, so please contact us separately.
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（2）
Download All Catalogs
Company information
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.